These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6301706

  • 21. Protective actions of naloxone in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Am J Physiol; 1980 Sep; 239(3):H416-21. PubMed ID: 7435587
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
    Gurll NJ, Reynolds DG, Vargish T, Lechner R.
    J Pharmacol Exp Ther; 1982 Mar; 220(3):625-8. PubMed ID: 6278127
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE, Martini A, Sacerdote P, Mantegazza P.
    Brain Res; 1984 Jun 18; 304(1):153-6. PubMed ID: 6331578
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 18; 277(1):484-90. PubMed ID: 8613958
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H, Lefer DJ, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1987 Jun 18; 9(6):341-7. PubMed ID: 3116357
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE, Harrison LM, Ge LJ, Kastin AJ, Chang SL.
    J Pharmacol Exp Ther; 1994 Sep 18; 270(3):1086-96. PubMed ID: 7932156
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E, Neruda B, Smith OW.
    Arzneimittelforschung; 1997 Jan 18; 47(1):6-9. PubMed ID: 9037435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.